Table 3. Middle- and long-term effects of ultrasound screening*1.
Follow-up at 3–5 years | Screening, n = 62 729 | Control, n = 62 847 | Odds ratio (95% CI) | P |
AAA-related deaths | 102 | 182 | 0.56 (0.44–0.72) | < 0.0001 |
Overall deaths | 7 453 | 7 953 | 0.94 (0.86–1.02) | 0.14 |
Elective AAA ‧operations | 505 | 162 | 3.27 (2.15–5.00) | < 0.0001 |
Emergency ‧operations | 55 | 101 | 0.55 (0.39–0.76) | 0.0003 |
Follow-up at 7–15 years | Screening, n = 43 167 | Control, n = 43 312 | Odds ratio (95% CI) | P |
AAA-related deaths | 123 | 245 | 0.47 (0.25–0.90) | 0.02 |
Overall deaths*2 | 14 922 | 15 568 | 0.94 (0.91–0.97) | < 0.0001 |
Elective AAA ‧operations | 567 | 204 | 2.81 (2.40–3.30) | < 0.0001 |
Emergency ‧operations | 77 | 172 | 0.48 (0.28–0.83) | 0.009 |
*1 Effects in men aged 64 to 83 years in four randomized studies (Chichester, MASS, Viborg, Western Australia).
*2 Includes long-term results from the Australian study, i.e., 62 519 screened patients and 62 664 controls.